Uniting Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$953K Sell
794
-1
-0.1% -$1.02K 0.19% 82
2026
Q1
$731K Buy
795
+58
+8% +$58.8K 0.16% 88
2025
Q4
$792K Buy
737
+305
+71% +$292K 0.24% 59
2025
Q3
$330K Buy
+432
New +$321K 0.08% 132

Other funds holding LLY

Uniting Wealth Partners's LLY Position: Q2 2026 in Review

Uniting Wealth Partners reduced its Eli Lilly (LLY) stake by 0.13% in Q2 2026, selling an estimated $1.02K and leaving 794 shares worth $953K. The position accounts for 0.19% of the portfolio, ranked #82.

Uniting Wealth Partners first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Uniting Wealth Partners held 794 shares of Eli Lilly worth $953K as of Q2 2026.
  • Uniting Wealth Partners sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.19% of Uniting Wealth Partners's portfolio in Q2 2026, its #82 holding.
  • Uniting Wealth Partners first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Uniting Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.